Site selective synthesis and anti-inflammatory evaluation of Spiro-isoxazoline stitched adducts of arteannuin B
| Autor: | Javeed Rasool, Majeed Shaikh, Sreedhar Madishetti, Zabeer Ahmed, Yedukondalu Nalli, Asif Ali, Gifty Sawhney |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.drug_class
Organic Chemistry Anti-Inflammatory Agents Isoxazoles Pharmacology Nitric Oxide Biochemistry Anti-inflammatory Artemisinins Nitric oxide chemistry.chemical_compound Mice RAW 264.7 Cells chemistry Drug Discovery Toxicity medicine Macrophage Animals Cytokines Stereoselectivity Tumor necrosis factor alpha Cytotoxicity Molecular Biology IC50 |
| Zdroj: | Bioorganic chemistry. 117 |
| ISSN: | 1090-2120 |
| Popis: | A library of new spiroisoxazoline analogues of arteannuin B was synthesized through 1, 3-dipolar cycloaddition in stereoselective fashion and consequently screened for anti-inflammatory activity in RAW 264.7 macrophage cells. Three potent analogues (8i, 8 m, and 8n) were found to attenuate the LPS induced release of cytokines IL-6 and TNF-α more potently than the parent molecule. Also, the inhibition of LPS induced nitric oxide production in these cells show moderate to high efficacy. None of the three potent molecules have altered the viability of RAW 264.7 cells following 48 h incubation suggesting that the inhibition of cytokines and nitric oxide production exhibited in the cells was not due to toxicity. In addition, these compounds exhibit an IC50 range of 0.17 µM-1.57 µM and 0.09 µM-0.35 µM for the inhibition of IL-6 release and nitric oxide production respectively. The results disclose potent inhibition of pro-inflammatory mediators which are encouraging and warrant further investigations to develop new therapeutic agents for inflammatory diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect